Table of Contents
Analgesics in Brazil
Euromonitor International
May 2009
List of
Contents and Tables
Executive Summary
Positive Economy Indicators Push
Sales of OTC Healthcare
New Rules for OTC Advertising
Hypermarcas
Acquires Dm Indústria Farmacêutica and Farmasa
Further
Consolidation of Drugstores
Slowdown Growth in the Next Two Years
Key
Trends and Developments
Further Restriction To Advertising of OTC
Products
Hypermarcas Acquires Two Leading OTC Manufacturers
Specific
Department for OTC Products Established Within Anvisa
Financial Crisis
Affects OTC Products
Senior Consumers and Women Over 40 Years Old Attract
Investment
Market Indicators
Table 1 Consumer Expenditure on Health
Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth
2003-2008
Market Data
Table 3 Sales of OTC Healthcare by Sector: Value
2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth
2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Sales of
OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 8 Sales
of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table
9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 10
Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC Registration and Classification
De-reimbursement
Advertising
Packaging and Labelling
Distribution
Vitamins and
Dietary Supplements Registration and Classification
Self-medication and
Preventative Medicine
Generics
Switches
Summary 1 OTC Healthcare
Switches 2005-2007
Definitions
Summary 2 Research Sources
Aché Laboratórios Farmacêuticos SA
Strategic Direction
Key Facts
Summary 3 Aché Laboratórios Farmacêuticos SA: Key
Facts
Summary 4 Aché Laboratórios Farmacêuticos SA:
Operational Indicators
Company Background
Production
Summary 5
Aché Laboratórios Farmacêuticos SA: Production Statistics
2007
Competitive Positioning
Summary 6 Aché Laboratórios
Farmacêuticos SA: Competitive Position 2008
Bayer SA
Strategic
Direction
Key Facts
Summary 7 Bayer SA: Key Facts
Summary 8 Bayer
SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 9 Bayer SA: Competitive Position 2008
Boehringer Ingelheim Do Brasil Química E Farmacêutica Ltda
Strategic Direction
Key Facts
Summary 10 Boehringer Ingelheim do
Brasil Química e Farmacêutica Ltda: Key Facts
Summary 11
Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda:
Operational Indicators
Company Background
Production
Summary 12
Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda:
Production Statistics 2007
Competitive Positioning
Summary 13
Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda:
Competitive Position 2008
Dm Indústria Farmacêutica Ltda
Strategic Direction
Key Facts
Summary 14 DM Indústria
Farmacêutica Ltda: Key Facts
Summary 15 DM Indústria
Farmacêutica Ltda: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 16 DM Indústria
Farmacêutica Ltda: Competitive Position 2008
Ems SA
Strategic
Direction
Key Facts
Summary 17 EMS SA: Key Facts
Summary 18 EMS
SA: Operational Indicators
Company Background
Production
Summary
19 EMS SA: Production Statistics 2007
Competitive Positioning
Summary
20 EMS SA: Competitive Position 2008
Eurofarma Laboratório Ltda
Strategic Direction
Key Facts
Summary 21 Eurofarma Laboratório
Ltda: Key Facts
Summary 22 Eurofarma Laboratório Ltda: Operational
Indicators
Company Background
Production
Summary 23 Eurofarma
Laboratório Ltda: Production Statistics 2007
Competitive
Positioning
Summary 24 Eurofarma Laboratório Ltda: Competitive
Position 2008
Janssen-cilag Farmaceutica Ltda
Strategic Direction
Key Facts
Summary 25 Janssen-Cilag Farmacêutica Ltda: Key Facts
Company Background
Production
Competitive Positioning
Summary 26
Janssen-Cilag Farmacêutica Ltda: Competitive Position 2008
Medley SA
Indústria Farmacêutica
Strategic Direction
Key Facts
Summary 27 Medley SA Indústria Farmacêutica: Key Facts
Summary
28 Medley SA Indústria Farmacêutica: Operational Indicators
Company Background
Production
Summary 29 Medley SA Indústria
Farmacêutica: Production Statistics 2007
Competitive Positioning
Summary 30 Medley SA Indústria Farmacêutica: Competitive Position
2008
Nycomed Pharma Ltda
Strategic Direction
Key Facts
Summary
31 Nycomed Pharma Ltda: Key Facts
Summary 32 Nycomed Pharma Ltda:
Operational Indicators
Company Background
Production
Summary 33
Nycomed Pharma Ltda: Production Statistics 2007
Competitive
Positioning
Summary 34 Nycomed Pharma Ltda: Competitive Position 2008
Sanofi-aventis Farmacêutica Ltda
Strategic Direction
Key
Facts
Summary 35 Sanofi-Aventis Farmacêutica Ltda: Key Facts
Summary 36 Sanofi-Aventis Farmacêutica Ltda: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 37
Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2008
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 11 Sales of Analgesics by Subsector: Value 2003-2008
Table 12 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table
13 Herbal vs Standard Topical Analgesics 2003-2008
Table 14 Topical
Analgesics by Format: % Value Breakdown 2004-2008
Table 15 Analgesics
Company Shares by Value 2004-2008
Table 16 Analgesics Brand Shares by
Value 2005-2008
Table 17 Forecast Sales of Analgesics by Subsector: Value
2008-2013
Table 18 Forecast Sales of Analgesics by Subsector: % Value
Growth 2008-2013
| 
View Cart
